Position in AZN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$850,011,848
+$20,859,722 QoQ
Shares Held
4,482,712
+6.6% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
4.44%
of 13F equity value
Holder Rank
#44
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026M&G PLC holds $1,479,850,248 across 11 Drug Manufacturers - General names. AZN ranks #1 (57.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
4,482,712 | $850,011,848 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
5,292,229 | $304,938,234 | |
| 3 | ABBV |
AbbVie Inc.
|
579,447 | $145,812,043 | |
| 4 | AMGN |
Amgen Inc
|
289,819 | $104,949,256 | |
| 5 | MRK |
Merck & Co., Inc.
|
210,965 | $27,109,002 | |
| 6 | JNJ |
Johnson & Johnson
|
52,505 | $13,334,694 | |
| 7 | PFE |
Pfizer Inc
|
418,626 | $10,080,514 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
78,527 | $9,921,101 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $850,011,848 | 4,482,712 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $829,152,126 | 4,204,199 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||